How important are concurrent vehicle control groups in (sub)chronic non-human primate toxicity studies conducted in pharmaceutical development? An opportunity to reduce animal numbers
L. Mecklenburg, S. Lenz, G. Hempel
This study evaluates the necessity of concurrent vehicle control groups in non-human primate toxicity studies and suggests alternatives to reduce animal use.
bioRxiv · Feb 15, 2023Pharmacology & Toxicology